๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

97 POSTER A phase I dose-escalation study of the safety and pharmacokinetics of a novel spectrum selective kinase inhibitor, XL820, administered orally to patients with solid tumors

โœ Scribed by K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolcher; M. Stein


Book ID
118623726
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
59 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES